Frequency of Admission with Hereditary Blood Diseases in Paediatric Wards of Basrah Hospitals Iraq

Authors

  • Dhuha Sabeeh Jumaa Author
  • Basim A. Al Hijaj Author
  • Melad Abdulsalam Ibrahim Author
  • Nabaa Adil Makki Author
  • Adyan Abbas Fadhil Author

DOI:

https://doi.org/10.60110/medforum.360607

Keywords:

Hemoglobinopathies, Sickle cell disease, Thalassemia, Inpatient, Admission, Hemoglobinopathies, Sickle cell disease, Thalassemia, Inpatient, Admission

Abstract

Objective: To Identify the Causes & Patient Characteristics of Hereditary Blood Diseases of Basrah City Iraq.
Study Design: Retrospective study
Place and Duration of Study: This study was conducted at the Basrah Medical College, Iraq from 1st July 2022 to 31st December 2023.
Methods: This retrospective study reviewed patient records from the hematology ward of a hospital and found that 1,799 inherited hemoglobin disorder patients.
Results: All patients were under 15 years of age, with the majority (34.5%) in the 6–10 years. Of the total patients, 55.48% were male, resulting in a male-to-female ratio of 1.24. Sickle cell–related complications and morbidity were the predominant causes of admission, accounting for 64.48% of the cases. Outpatient referrals constituted the primary pathway for admission, with approximately half of the cases originating from the center and 97.44%. Most patients (88.6%) had a hospital stay of fewer than five days. Only 0.67% (12 patients) had prolonged stays (exceeding 15 days), primarily due to sickle cell–related morbidities. The average length of stay was 2.003 days, the range being 0–35 days.
Conclusion: Most of the admission trend was toward sickle cell and complications and recommendations were toward more preventive efforts toward vasoclosive pain and other complications in sickle cell patients

Downloads

Published

2025-07-12

Issue

Section

Original Articles

How to Cite

Frequency of Admission with Hereditary Blood Diseases in Paediatric Wards of Basrah Hospitals Iraq. (2025). Medical Forum Monthly, 36(6). https://doi.org/10.60110/medforum.360607